Wilmington, DE – The Pistoia Alliance, an organization dedicated to improving global life sciences R&D, has engaged additional resources as it expands its capabilities to support the implementation of its new strategy.
Previse Consulting will support the Pistoia Alliance’s various activities in assisting start-up companies, this includes the President’s Start-Up Challenge and the Mini Start-Up Challenge. Kalleid Inc. will be assisting with business development activities in the US, a key market for the Pistoia Alliance as it looks to increase its relevance and expand its activities.
Previse’s David Proudlock was most recently at GSK where he held a number of roles including Director, Innovation and Disruptive Technologies, along with a series of roles in IT and cheminformatics. Kalleid’s Mary Beth Walsh previously worked for BioDuro and Vertex Pharmaceuticals where she held senior business development roles.
Steve Arlington, President of the Pistoia Alliance, said: “The engagement of Previse and Kalleid are extremely important for the evolving Pistoia Alliance strategy. The US is an important market and through Mary Beth we can expand our presence there. Alongside this, David will be responsible for managing the start up competitions, an established and growing part of the Pistoia Alliance’s new approach to supporting innovation in life sciences”.